Status:
COMPLETED
Surgery in Addition to the Medical Treatment of Lymphedema
Lead Sponsor:
University Hospital, Montpellier
Collaborating Sponsors:
Department of Reconstructive surgery, UH Montpellier
Department of vascular medecine, UH Montpellier
Conditions:
Optimal Treatment of Lymphedema
Eligibility:
All Genders
18+ years
Brief Summary
Lymphedema is a chronic pathology with a real impact on the quality of life of patients. Despite optimal medical management of patients, some patients still have no pitting edema on which the medical ...
Detailed Description
Detailed Description: This is a monocentric, observational cohort study. Main judgment criteria: Evolution of the quality of life score of the LYMQOL self-questionnaire between preoperative and pos...
Eligibility Criteria
Inclusion
- no pitting edema
- good therapeutic compliance
- weight stability
Exclusion
- \- under 18 years old
Key Trial Info
Start Date :
April 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT03776214
Start Date
April 1 2018
End Date
December 31 2019
Last Update
March 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uhmontpellier
Montpellier, France, 34295